A4B17

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

A4B17 

A4B17 是一种治疗雄激素反应性前列腺癌的雄激素受体N-末端抑制剂。

A4B17

A4B17 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

A4B17 is an androgen receptor N-terminal inhibitor for treating androgen-responsive prostate cancer.

分子量

297.27

Formula

C14H7F4NS

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Kuznik NC, et al. Development of a Benzothiazole Scaffold-Based Androgen Receptor N-Terminal Inhibitor for Treating Androgen-Responsive Prostate Cancer. ACS Chem Biol. 2021 Nov 19;16(11):2103-2108.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务